JP2009138000A5 - - Google Patents

Download PDF

Info

Publication number
JP2009138000A5
JP2009138000A5 JP2009018865A JP2009018865A JP2009138000A5 JP 2009138000 A5 JP2009138000 A5 JP 2009138000A5 JP 2009018865 A JP2009018865 A JP 2009018865A JP 2009018865 A JP2009018865 A JP 2009018865A JP 2009138000 A5 JP2009138000 A5 JP 2009138000A5
Authority
JP
Japan
Prior art keywords
formula
compound according
converted
compound
under sufficient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2009018865A
Other languages
English (en)
Japanese (ja)
Other versions
JP5097724B2 (ja
JP2009138000A (ja
Filing date
Publication date
Priority claimed from US08/985,876 external-priority patent/US6262283B1/en
Application filed filed Critical
Publication of JP2009138000A publication Critical patent/JP2009138000A/ja
Publication of JP2009138000A5 publication Critical patent/JP2009138000A5/ja
Application granted granted Critical
Publication of JP5097724B2 publication Critical patent/JP5097724B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2009018865A 1996-12-06 2009-01-29 アミノステロール、ビタミンd類似体および他の化合物の製造に有用な24−ヒドロキシル化された化合物の立体選択的合成 Expired - Lifetime JP5097724B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US3237896P 1996-12-06 1996-12-06
US60/032,378 1997-12-05
US08/985,876 US6262283B1 (en) 1996-12-06 1997-12-05 Stereoselective synthesis of 24-hydroxylated compounds useful for the preparation of aminosterols, vitamin D analogs, and other compounds
US08/985,876 1997-12-05

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP52401298A Division JP4441769B2 (ja) 1996-12-06 1997-12-08 アミノステロール、ビタミンd類似体および他の化合物の製造に有用な24−ヒドロキシル化された化合物の立体選択的合成

Publications (3)

Publication Number Publication Date
JP2009138000A JP2009138000A (ja) 2009-06-25
JP2009138000A5 true JP2009138000A5 (enExample) 2009-11-12
JP5097724B2 JP5097724B2 (ja) 2012-12-12

Family

ID=26708341

Family Applications (2)

Application Number Title Priority Date Filing Date
JP52401298A Expired - Lifetime JP4441769B2 (ja) 1996-12-06 1997-12-08 アミノステロール、ビタミンd類似体および他の化合物の製造に有用な24−ヒドロキシル化された化合物の立体選択的合成
JP2009018865A Expired - Lifetime JP5097724B2 (ja) 1996-12-06 2009-01-29 アミノステロール、ビタミンd類似体および他の化合物の製造に有用な24−ヒドロキシル化された化合物の立体選択的合成

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP52401298A Expired - Lifetime JP4441769B2 (ja) 1996-12-06 1997-12-08 アミノステロール、ビタミンd類似体および他の化合物の製造に有用な24−ヒドロキシル化された化合物の立体選択的合成

Country Status (7)

Country Link
US (2) US6262283B1 (enExample)
EP (1) EP0942918A2 (enExample)
JP (2) JP4441769B2 (enExample)
AU (1) AU746559B2 (enExample)
CA (1) CA2272721C (enExample)
ES (1) ES2486840T3 (enExample)
WO (1) WO1998024800A2 (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7410959B1 (en) 2000-07-13 2008-08-12 Genaera Corporation Therapeutic uses for aminosterol compounds
EP1105407B1 (en) * 1998-08-12 2007-10-10 Genaera Corporation Aminosterol compounds and uses thereof
US6359012B1 (en) * 1999-12-22 2002-03-19 Bone Care International, Inc. Method for making 24(S)-hydroxyvitamin D2
EP1274718B1 (en) 2000-04-12 2006-10-18 Genaera Corporation A process for the preparation of 7.alpha.-hydroxy 3-aminosubstituted sterols using intermediates with an unprotected 7.alpha.-hydroxy group
US7319112B2 (en) 2000-07-14 2008-01-15 The Procter & Gamble Co. Non-halogenated antibacterial agents and processes for making same
US20030181742A1 (en) * 2000-09-08 2003-09-25 Makoto Nakazawa Process for the preparation of pregnane derivatives
DE60230299D1 (de) 2001-09-04 2009-01-22 Kuraray Co 7alpha-hydroxypregn-4-en-3-on,20-carbaldehyd und verfahren zur herstellung davon sowie verfahren zur herstellung von 7alpha,21-dihydroxy-20-methylpregn-4-en-3-on daraus
MXPA04006741A (es) * 2002-01-10 2006-05-31 Teva Pharma Esterificacion enzimatica selectiva y solvolisis de un analogo de vitamina d epimerico y separacion de los epimeros.
JP4667450B2 (ja) * 2004-03-18 2011-04-13 レオ ファーマ アクティーゼルスカブ ビタミンd類似体の立体選択的合成
US8362287B2 (en) 2004-03-18 2013-01-29 Leo Pharma A/S Stereoselective synthesis of vitamin D analogues
US20060052350A1 (en) * 2004-07-01 2006-03-09 Alexei Ploutno Crystalline forms of 1,24(S)-dihydroxy vitamin D2
US7557097B2 (en) * 2004-11-20 2009-07-07 Regents Of The University Of Minnesota Structural, behavioral characterization, and synthesis of attractants for migratory lamprey
EP1837343A4 (en) * 2004-12-08 2009-07-29 Kuraray Co METHOD OF PREPARING BENZOIC ACID (5 ', 7') - 3-SPIRO-2 '- (1', 3'-DIOXILANE) -24-OXOCHOLEST-22-EN-7-YLESTER
CA2606077C (en) 2005-04-25 2013-07-09 Genaera Corporation Polymorphic and amorphous salt forms of squalamine dilactate
US8040592B2 (en) * 2006-07-06 2011-10-18 Basf Se Encapsulated dispersions comprising electrophoretically mobile organic colorants
WO2008038965A1 (en) * 2006-09-26 2008-04-03 Kyungpook National University Industry-Academic Cooperation Foundation 7alpha-aminosteroid derivatives or pharmaceutically acceptable salts thereof, preparation method thereof and composition for anticancer or antibiotics containing the same as an active ingredient
US20080318870A1 (en) 2007-06-19 2008-12-25 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
US8242294B2 (en) 2007-06-19 2012-08-14 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
JOP20180077A1 (ar) 2007-06-19 2019-01-30 Kythera Biopharmaceuticals Inc تركيبات وطرق لحمض صفراوي تخليقي
WO2009032321A2 (en) * 2007-09-06 2009-03-12 Genaera Corporation A method for treating diabetes
KR100876857B1 (ko) * 2008-02-15 2008-12-31 경북대학교 산학협력단 7-플루오로-3-아미노스테로이드 유도체 또는 이의약학적으로 허용가능한 염, 이의 제조방법 및 이를유효성분으로 함유하는 항균용 약학적 조성물
WO2012021133A1 (en) 2010-08-12 2012-02-16 Kythera Biopharmaceuticals, Inc. Synthetic bile acid compositions and methods
KR101845107B1 (ko) 2010-08-17 2018-04-03 오에이치알 파마서티컬, 인코포레이티드 스쿠알라민 안약 제제
US20130261317A1 (en) * 2010-09-27 2013-10-03 Kythera Biopharmaceuticals, Inc. Methods for preparing synthetic bile acids and compositions comprising the same
EP4469466A1 (en) * 2022-01-25 2024-12-04 Enterin, Inc. C25 r and s isomers of aminosterols and methods of making and using the same
CN116836214B (zh) * 2022-03-25 2024-07-09 苏州恩泰新材料科技有限公司 一种7-酮石胆酸中间体的合成方法和应用

Family Cites Families (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016390A (en) 1960-06-30 1962-01-09 Searle & Co N-(substituted alkyl) amino-5alpha-androstan-17beta-ols
US3370070A (en) 1965-06-16 1968-02-20 Searle & Co [n-alkyl-17-(dialkylaminoalkyl)amino] androst-4-en-3-ones
GB1565351A (en) 1975-06-02 1980-04-16 Theramex Steroid aminoethers
US4220598A (en) 1977-11-14 1980-09-02 Abbott Laboratories Method and reagents for measuring the level of conjugated bile acids
US4550163A (en) 1979-02-05 1985-10-29 Abbott Laboratories Ligand analog-irreversible enzyme inhibitor conjugates
US4372888A (en) 1980-08-26 1983-02-08 The United States Of America As Represented By The Secretary Of The Department Of Health & Human Services Nondenaturing zwitterionic detergents
JPS5842878B2 (ja) 1981-12-02 1983-09-22 名糖産業株式会社 12−オキソコラン酸トシルヒドラゾン化合物、その製法ならびに利用
FR2523745B1 (fr) * 1982-03-18 1987-06-26 Bull Sa Procede et dispositif de protection d'un logiciel livre par un fournisseur a un utilisateur
DE3366932D1 (en) 1982-07-29 1986-11-20 Lehner Ag New derivatives of biliary acids, process for the production thereof and pharmaceutical compositions containing the same
US5001116A (en) 1982-12-20 1991-03-19 The Children's Medical Center Corporation Inhibition of angiogenesis
US4994443A (en) 1982-12-20 1991-02-19 The Children's Medical Center Corporation Inhibition of angiogenesis
IT1221734B (it) 1983-02-24 1990-07-12 Schiena Michele Giuseppe Di Ursodesossicolico solfato acido sale sodico
US4545938A (en) 1983-11-02 1985-10-08 Beth Israel Medical Center Chemical synthesis
EP0243449A1 (en) 1985-10-18 1987-11-04 The Upjohn Company Cyclic hydrocarbons with an aminoalkyl sidechain
US4771042A (en) 1985-11-25 1988-09-13 The Upjohn Company Inhibition of angiogenesis involving the coadministration of steroids with heparin or heparin fragments
JPS62175497A (ja) 1986-01-28 1987-08-01 Wakunaga Pharmaceut Co Ltd 胆汁酸誘導体およびその製造法
US5075464A (en) 1987-04-22 1991-12-24 Merrell Dow Pharmaceuticals Inc. 17β-(cyclopropylamino)androstene derivatives
SE8702254D0 (sv) 1987-05-29 1987-05-29 Kabivitrum Ab Novel heparin derivatives
US4943635A (en) * 1987-08-27 1990-07-24 President & Fellows Of Harvard College Enantioselective reduction of ketones
US5135919A (en) 1988-01-19 1992-08-04 Children's Medical Center Corporation Method and a pharmaceutical composition for the inhibition of angiogenesis
IT1229569B (it) 1989-04-17 1991-09-04 Giuliani Spa Derivati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
IT1229570B (it) 1989-04-17 1991-09-04 Giuliani Spa Derivati fluorurati di acidi biliari, loro preparazione e composizioni farmaceutiche che li contengono.
JPH07116215B2 (ja) 1989-04-19 1995-12-13 エスエス製薬株式会社 新規なステロイド化合物
PT93847A (pt) 1989-04-24 1990-11-20 Harvard College Processo para a preparacao de oligossacaridos de baixo peso molecular derivados de heparina ou de sulfato de heparano despolimerizados e de composicoes farmaceuticas que os contem
US4966897A (en) 1989-08-15 1990-10-30 Merrell Dow Pharmaceuticals Inc. 4-substituted 17β-(cyclopropyloxy)androst-5-en-3β-ol and related compounds useful as C17-20 lyase inhibitors
US5004737A (en) 1989-09-22 1991-04-02 Pacific Chemical Co., Ltd. Quaternary ammonium-substituted sterol derivatives
EP0466315A3 (en) 1990-05-30 1992-07-01 Larrian Gillespie Compositions containing xylan sulphates for affecting growth factor function and for inhibiting fibroblast proliferation
DK0533703T3 (da) 1990-06-11 2000-08-14 Alcon Lab Inc Anvendelse af steroider til hæmning af angiogenese
US5250524A (en) 1990-12-06 1993-10-05 Hoechst Aktiengesellschaft Bile acid derivatives, process for their preparation and use of these compounds as pharmaceuticals
US5192756A (en) 1992-03-18 1993-03-09 The Children's Hospital Of Pennsylvania Aminosterol antibiotic
AU4534593A (en) 1992-06-12 1994-01-04 Affymax Technologies N.V. Compositions and methods for enhanced drug delivery
US5247104A (en) 1992-11-04 1993-09-21 Wisconsin Alumni Research Foundation Preparation of 1α, 24-dihydroxyvitamin D analogs
JPH06329679A (ja) 1993-01-20 1994-11-29 Nissan Chem Ind Ltd 光学活性β−アミノアルコキシボラン錯体
AU6392894A (en) 1993-02-26 1994-09-14 Magainin Pharmaceuticals, Inc. Chemical synthesis of squalamine
ATE169930T1 (de) 1993-03-10 1998-09-15 Magainin Pharma Steroidderivate, pharmazeutische zusammensetzungen die sie enthalten und ihre verwendung als antibiotika oder desinfektionsmittel
PT749437E (pt) 1994-03-10 2002-03-28 Magainin Pharma Utilizacoes farmaceuticas de derivados de esteroides
US5792635A (en) * 1995-06-07 1998-08-11 Magainin Pharmaceuticals, Inc. Method of inhibiting the sodium/proton exchanger NHE3 and method of inhibiting growth by administering squalamine
PT832094E (pt) * 1995-06-07 2004-06-30 Genaera Corp Compostos de aminoesterol uteis como inibidores do permutador sodio/protao )nhe) metodos e composicoes farmaceuticas empregando estes inibidores e processos para avaliacao da eficacia inibidora de nhe dos compostos
US5623546A (en) * 1995-06-23 1997-04-22 Motorola, Inc. Encryption method and system for portable data
ATE223173T1 (de) 1996-04-29 2002-09-15 Koninkl Philips Electronics Nv Brotröster mit sicherheitseinrichtung zum anzeigen des spannungszustandes

Similar Documents

Publication Publication Date Title
JP2009138000A5 (enExample)
WO2011024192A3 (en) Novel polymorphs of raltegravir
JP2011518833A5 (enExample)
EP2248805A3 (en) Method of synthesis of bosentan, its polymorphic forms and its salts
PT2453739E (pt) Processo para a preparação de uma suspensão aquosa de um composto pesticida orgânico
MY170520A (en) Method of synthesizing thyroid hormone analogs and polymorphs thereof
JP2009149903A5 (enExample)
WO2010080242A3 (en) Uzm-27 family of crystalline aluminosilicate compositions, a method of preparing the compositions and methods of using the compositions
JP2015129106A5 (enExample)
WO2011022596A3 (en) Preparation of bazedoxifene and its salts
JP2013532130A5 (enExample)
WO2010001257A3 (en) Novel solid state forms of laquinimod and its sodium salt
WO2011004402A3 (en) Improved process for the preparation of ambrisentan and novel intermediates thereof
NZ739219A (en) Methods for preparation of bile acids and derivatives thereof
EP2403801A4 (en) METHOD FOR PRODUCING COHESIVE CARBON ASSEMBLY
EP3444238A3 (en) Process for preparing difluoromethylene compounds
JP2011511794A5 (ja) 塩の製造のための方法
WO2013014665A8 (en) Intermediate compounds and process for the preparation of lurasidone and salts thereof
RU2013137753A (ru) Твердые формы ингибитора гиразы (r)-1-этил-3-[5-[2-(1-гидрокси-1-метилэтил)пиримидин-5-ил]-7-(тетрагидрофуран-2-ил)-1н-бензимидазол-2-ил]мочевины
ATE500226T1 (de) Aripiprazolhemifumarat und verfahren zu dessen herstellung
WO2011004387A3 (en) Process for the preparation of dexlansoprazole polymorphic forms
UA106988C2 (uk) Спосіб одержання 1-бензил-3-гідроксиметил-1h-індазолу і його похідних та необхідні проміжні сполуки магнію
JP2013234194A5 (enExample)
WO2012148148A3 (en) Novel zinc azide complex and a process for preparing tetrazole derivatives using the same
JP2017509581A5 (enExample)